AC Immune SA (ACIU)
2.43
-0.02
(-0.82%)
USD |
NASDAQ |
Oct 16, 11:23
AC Immune SG&A Expense (TTM) : 19.51M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 19.51M |
| March 31, 2026 | 19.75M |
| December 31, 2025 | 19.36M |
| September 30, 2025 | 18.66M |
| June 30, 2025 | 18.53M |
| March 31, 2025 | 18.85M |
| December 31, 2024 | 19.59M |
| September 30, 2024 | 19.62M |
| June 30, 2024 | 19.21M |
| March 31, 2024 | 18.27M |
| December 31, 2023 | 17.02M |
| September 30, 2023 | 16.56M |
| June 30, 2023 | 16.03M |
| March 31, 2023 | 16.46M |
| December 31, 2022 | 16.54M |
| September 30, 2022 | 15.59M |
| June 30, 2022 | 18.11M |
| March 31, 2022 | 19.33M |
| December 31, 2021 | 19.60M |
| September 30, 2021 | 21.98M |
| June 30, 2021 | 21.39M |
| March 31, 2021 | 19.96M |
| December 31, 2020 | 19.82M |
| September 30, 2020 | 19.56M |
| Date | Value |
|---|---|
| June 30, 2020 | 18.25M |
| March 31, 2020 | 17.52M |
| December 31, 2019 | 16.17M |
| September 30, 2019 | 14.67M |
| June 30, 2019 | 13.63M |
| March 31, 2019 | 13.17M |
| December 31, 2018 | 12.72M |
| September 30, 2018 | 12.06M |
| June 30, 2018 | 11.70M |
| March 31, 2018 | 10.80M |
| December 31, 2017 | 10.32M |
| September 30, 2017 | 10.62M |
| June 30, 2017 | 9.764M |
| March 31, 2017 | 9.468M |
| December 31, 2016 | 7.995M |
| September 30, 2016 | 4.568M |
| June 30, 2016 | 3.734M |
| March 31, 2016 | 1.827M |
| December 31, 2015 | 0.9222M |
| September 30, 2015 | 0.9222M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Precigen, Inc. | 84.93M |
| Basilea Pharmaceutica AG | 45.60M |
| Santhera Pharmaceuticals Holding AG | 18.92M |
| Aldeyra Therapeutics, Inc. | 8.438M |
| BeOne Medicines Ltd. | 2.238B |